Cyclizine
Sold as Medazine nausea, Medazine s, Adco-cyclizine, Ryccard /tablette, Ryccard ped, Nauzine*, Emitex, Covamet, Cycloid /stoop, Cycloid, Nauzine s, Pinaloid, Valoid as, Valoid children's, Valoid, Valoid paediatric, Triazine, Maldemar, Aculoid, Norizine, Triazine paediatric
Background
Registration
- Applicants
- 8
- Registrations
- 27
- Schedule source
- SAHPRA documentation
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Cipla Medpro (Pty) Ltd | Medazine nausea | tablets | 270203 | Not determined | None |
| Medpro Pharmaceutica (Pty) LtdCertificate held by Cipla Medpro (Pty) Ltd.1 of 2 cancelled | Medazine s, Pinaloid | 5 ml | 270204, 330466 | S2 | PIPIL |
| Adcock ingram limited3 of 6 cancelled | Adco-cyclizine, Ryccard /tablette, Ryccard ped, Covamet | syrup, 50 mg, tablets/tablette, tablets | 270259, 270386, 270484, 270503, 280499, 280533 | Not determined | None |
| Ranbaxy (SA) (Pty) LtdCancelled | Nauzine*, Nauzine s | tablet | 270535, 290238 | Not determined | None |
| Pharmacare limited û woodmead4 of 11 cancelled | Emitex, Valoid as, Valoid children's, Valoid, Valoid paediatric, Triazine, Norizine, Triazine paediatric | tablets, syrup, suppositories, 50 mg, 100 mg | 280435, 280436, C0975, C0977, C0978, D0097, M0160, M0161, N0168, X0200, X0382 | Not determined | None |
| Acino Pharma (Pty) Ltd | Cycloid /stoop, Cycloid | syrup/stoop, tablets | 280705, 290032 | Not determined | None |
| The Premier Pharmaceutical Co LtdCancelled | Maldemar | Not stated | V0335 | Not determined | None |
| Teva Pharmaceuticals (Pty) LtdCancelled | Aculoid | syrup, tablets | X0005, Z0228 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Medazine nausea tablets EACH TABLET CONTAINS CYCLIZINE HYDROCHLORIDE 50 mg | Tablets | 27020327/5.7.2/0203 | Registered | Not determined | None |
| Medazine s 5 ML CYCLIZINE HYDROCHLORIDE 12,5 MG | 5 mlSyrup | 27020427/5.7.2/0204Approved 20 February 2023 | Registered | S2 | PIPIL |
| Adco-cyclizine syrup EACH 5 ml SYRUP CONTAINS CYCLIZINE HYDROCHLORIDE 12,5 mg | Syrup | 27025927/5.7/0259 | Registered | Not determined | None |
| Adco-cyclizine 50 MG EACH TABLET CONTAINS CYCLIZINE HYDROCHLORIDE 50 mg | 50 mg | 27038627/5.7.2/0386 | Registered | Not determined | None |
| Ryccard tablets/tablette EACH TABLET CONTAINS CYCLIZINE HYDROCHLORIDE 50 mg | Tablets/tablette | 27048427/5.7.2/0484 | Cancelled | Not determined | None |
| Ryccard ped EACH 5 ml SYRUP CONTAINS CYCLIZINE HYDROCHLORIDE 12,5 mg | Not listed | 27050327/5.7/0503 | Cancelled | Not determined | None |
| Nauzine* tablet EACH TABLET CONTAINS CYCLIZINE HYDROCHLORIDE 50 mg | Tablet | 27053527/5.7.2/0535 | Cancelled | Not determined | None |
| Emitex tablets EACH TABLET CONTAINS CYCLIZINE HYDROCHLORIDE 50 mg | Tablets | 28043528/5.7.2/0435 | Registered | Not determined | None |
| Emitex syrup EACH 5 ml CONTAINS CYCLIZINE HYDROCHLORIDE 12,5 mg | Syrup | 28043628/5.7/0436 | Cancelled | Not determined | None |
| Covamet tablets EACH TABLET CONTAINS CYCLIZINE HYDROCHLORIDE 50 mg | Tablets | 28049928/5.7/0499 | Registered | Not determined | None |
| Covamet syrup EACH 5,0 ml SYRUP CONTAINS CYCLIZINE HYDROCHLORIDE 12,5 mg | Syrup | 28053328/5.7/0533 | Cancelled | Not determined | None |
| Cycloid syrup/stoop EACH 5 ML SYRUP CONTAINS CYCLIZINE HYDROCHLORIDE 12,5 MG | Syrup/stoop | 28070528/5.7/0705 | Registered | Not determined | None |
| Cycloid tablets TABLET CYCLIZINE HYDROCHLORIDE 50 MG | Tablets | 29003229/5.7.2/0032 | Registered | Not determined | None |
| Nauzine s* EACH 5 ml SYRUP CONTAINS CYCLIZINE HYDROCHLORIDE 12,5 mg | Not listed | 29023829/5.7.2/0238 | Cancelled | Not determined | None |
| Pinaloid EACH TABLET CONTAINS CYCLIZINE HYDROCHLORIDE 50,0 mg | Not listed | 33046633/5.7.2/0466 | Cancelled | Not determined | None |
| Valoid as EACH SUPPOSITORY CONTAINS CYCLIZINE HYDROCHLORIDE 100,0 mg | Not listed | C0975C/5.7.2/975 | Registered | Not determined | None |
| Valoid children's suppositories EACH SUPPOSITORY CONTAINS CYCLIZINE HYDROCHLORIDE 50,0 mg | Suppositories | C0977C/5.7.2/977 | Registered | Not determined | None |
| Valoid EACH TABLET CONTAINS CYCLIZINE HYDROCHLORIDE 50 mg | Not listed | C0978C/5.7.2/978 | Registered | Not determined | None |
| Valoid paediatric syrup EACH 5,0 ml SYRUP CONTAINS CYCLIZINE HYDROCHLORIDE 12,5 mg | Syrup | D0097D/5.7/97 | Registered | Not determined | None |
| Triazine 50 MG suppositories EACH SUPPOSITORY CONTAINS CYCLIZINE HYDROCHLORIDE 50 mg | 50 mgSuppositories | M0160M/5.7.2/160 | Cancelled | Not determined | None |
| Triazine 100 MG suppositories EACH SUPPOSITORY CONTAINS CYCLIZINE HYDROCHLORIDE 100 mg | 100 mgSuppositories | M0161M/5.7.2/161 | Cancelled | Not determined | None |
| Triazine tablets EACH TABLET CONTAINS CYCLIZINE HYDROCHLORIDE 50 mg | Tablets | N0168N/5.7.2/168 | Registered | Not determined | None |
| Maldemar* EACH TABLET CONTAINS CYCLIZINE HYDROCHLORIDE 50 mg | Not listed | V0335V/5.7.2/335 | Cancelled | Not determined | None |
| Aculoid syrup EACH 5 ml SOLUTION CONTAINS CYCLIZINE HYDROCHLORIDE 12,5 mg | Syrup | X0005X/5.7/5 | Cancelled | Not determined | None |
| Norizine tablets EACH TABLET CONTAINS CYCLIZINE HYDROCHLORIDE 50 mg | Tablets | X0200X/5.7/200 | Cancelled | Not determined | None |
| Triazine paediatric syrup EACH 5 ml SYRUP CONTAINS CYCLIZINE HYDROCHLORIDE 12,5 mg | Syrup | X0382X/5.7/382 | Registered | Not determined | None |
| Aculoid tablets EACH TABLET CONTAINS CYCLIZINE HYDROCHLORIDE 50 mg | Tablets | Z0228Z/5.7.2/228 | Cancelled | Not determined | None |
Regulatory status
Where S2 sits on the scale
A pharmacist can sell it directly, without a prescription.
Schedule 2 medicines sit behind the pharmacy counter. A pharmacist can decide to sell one of these directly, using their own professional judgement, without a doctor's prescription. It can also be dispensed against a prescription like the higher tiers, in which case the usual repeat limits apply. A child under 12 may only be sold a Schedule 2 substance on a prescription, or on a written order that names the purpose and carries a signature the seller recognises. Even though it cannot be advertised to the public in the ordinary sense, its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S2, read from the product's PI-PIL leaflet.
Who may supply: Only a pharmacist, pharmacist intern or supervised pharmacist's assistant may sell it without a prescription. It may otherwise be dispensed by a pharmacist against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Cyclizine hydrochloride
S2: Cyclizine
Consolidated Schedules 06 July 2026, line 1785
Pharmacological class: Anti-emetics and antivertigo preparations. (class 5.7.2)
2 of 3 approved products with this ingredient carry S6 on their leaflet.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Medazine s, Medpro Pharmaceutica (Pty) Ltd is scheduled S2 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.